Cysteine-rich protein 61 (CCN1) and connective tissue growth factor (CCN2) at the crosshairs of ocular neovascular and fibrovascular disease therapy

Authors: A Das
A Hasan
A Leask
A Nakamura-Ishizu
AM Babic
B Perbal
BL Bader
BM Dulmovits
Brahim Chaqour
C Caprara
CC Chen
D Hilfiker-Kleiner
D Watanabe
DA Jans
DM Bryant
DR Brigstock
DR Hinton
E Heath
EJ Kuiper
EJ Kuiper
ER Tamm
F Hall-Glenn
FE Mo
FE Mo
G Bou-Gharios
G Workman
GA Lutty
H Chintala
H Liu
HA Mintz-Hittner
HA Quigley
HE Doherty
HY Lee
I Inoki
I Stalmans
I Tamura
IM Francischetti
JA Arnott
JI Jun
JM Hughes
JM Provis
JM Schober
JS Han
K Neelam
K Schwartz
KP Holbourn
KT Abd El
L Kennedy
LC Armstrong
LP Aiello
Lulu Yan
M Hanna
M Hendrickx
M Hirschfeld
M Saint-Geniez
M Zhu
MA Martinez-Castellanos
ME Hartnett
N Barzegar-Befroei
N Chen
N Planque
NA Wahab
P Bornstein
P Geraldes
PA Campochiaro
PR Segarini
R Fuchshofer
R Gao
R Yang
RJ Geest Van
RM Mason
S Caballero
S De
S He
S Ishida
S Ivkovic
S Perkowski
SM Chudgar
SM Twigg
SM Warden
SY Li
T Kita
T Shimo
T Shimoyama
V Juric
V Vogel
W Si
Y Chen
Y Jin
Y Liang
YH Kwon
Publication date
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Crossref

redirect

info:doi/10.1007%2Fs12079-013-...

Last time updated on 05/06/2019